Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells-Reference-Cited by-同舟云学术

Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells

Published:2002-05 Issue:3 Volume:25 Page:227-234
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Endo F.¹²,Sun M.-S.³

Affiliation:

1. ; Department of Pediatrics; Kumamoto University; Kumamoto Japan

2. ; Department of Pediatrics; Kumamoto University; Honjo 1-1-1 Kumamoto 860-8556 Japan

3. ; Heritable Disorders Branch, National Institute of Child Health and Human Development; National Institutes of Health; Bethesda Maryland USA

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1023/A:1015646400182/fullpdf

Reference23 articles.

1. Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I;Awata;Biochim Biophys Acta,1994

2. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia;Berger;Clin Chim Acta,1981

3. A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia;Endo;Am J Hum Genet,1991

4. A nonsense mutation in the 4-hydroxyphenylpyruvic acid dioxygenase gene (Hpd) causes skipping of the constitutive exon and hypertyrosinemia in mouse strain III;Endo;Genomics,1995

5. Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway;Endo;J Biol Chem,1997

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Fanconi Syndromes and Other Proximal Tubular Disorders;Pediatric Kidney Disease;2023

2. Activation of homology-directed DNA repair plays key role in CRISPR-mediated genome correction;Gene Therapy;2022-10-19

3. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions;Nature Communications;2022-08-25

4. Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders;Bioengineering;2022-08-15

5. Hereditary Tyrosinemia;Nutrition Management of Inherited Metabolic Diseases;2022